Looking for New Indications

Do you have an idea for a new indication using Bayer compounds?
Bayer is promoting the exploration of new indications by offering grants and further financial support.

Bayer offers grants to apply for study funding and support to assess and promote the exploration of new indications with Bayer compounds or drugs.

View How It Works

A Famous Example For New Indications in Bayer History: Aspirin

Many medications have originally been developed for a completely different indication. Only later, completely new indications have been identified, which in many cases, were even more successful than the original one. One example out of the Bayer history is aspirin. Originally developed as a drug against pain and fever, it is now also used for primary and secondary prevention of cardiovascular events due to its effect as a platelet aggregation inhibitor. Even today scientists are excited to investigate aspirin and obtain more data on further possible indications.

Your New Indication for a Bayer Compound

Grants4Indications™ is a platform where you can submit your ideas on a specific non-clinical or clinical research project to evaluate a Bayer compound in a new indication, i.e. an indication outside of those currently approved or in clinical trials. Join our efforts and expertise in a mechanism-based approach in which we potentially support your project idea, both financially and with respective compounds.

Grants for new indications

There are 2 rounds in the grant review process. If you are interested, please submit a non-confidential short proposal of the intended research to Bayer. A selection will be made according to pre-defined criteria. If you are successful in the first stage, you will be invited to send your full study proposal and will receive a grant for this purpose*. If successful in the next round, you can receive further funding to conduct the study under an Investigator-Initiated Research (IIR) agreement, subject to negotiation and according to fair market value.

*if in accordance with your local laws and compliance regulations and to be paid to your employer/institution

Advance your research supported by Bayer

We are offering support for research projects with focus on new indications outside of the indications presently pursued for Bayer compounds or approved Bayer drugs that may lead to novel therapies. The research support is intended to be with respective Bayer compounds as well as financial. The duration of the intended research shall be 2 years maximum. The terms and conditions under which we provide such support will be defined in a separate contract to be negotiated between the applicant and Bayer.

How It Works

1 Submit your short proposal
2 Review & Selection by Bayer experts
3 Submit your full study proposal; grant is paid to employer/institution
4 Assessment by Bayer experts & IIR agreement with Bayer
Upon invitation only

1. Submit a Short Proposal

In a first step, applicants are asked to submit a short proposal of the research they intend to do.

The short proposal shall include:

  • the substance / drug the applicant wants to use
  • the new indication in which it should be used
  • brief cost estimation
  • timelines
  • research design (clinical / non-clinical, number of participants,ect)
  • maximum of 1500 words or two pages

In addition, we’d like to receive a copy of your CV and any necessary publications relevant to your research.

Please note that any information that you submit is non-confidential.

2. Review of Short Proposal, Selection and Invitation to submit Full Proposal

All short proposals received in one call will be reviewed and scored by Bayer scientists from different functions.

Of the submitted short proposals, depending on the number of suitable applications, up to 12 projects will be selected by a dedicated Bayer-internal Grants4Indications Review Committee, according to pre-defined criteria.

Pre-defined criteria are e.g.:

  • scientific value and rationale
  • medical need in the intended indication
  • availability of treatment in the intended indication
  • soundness of experimental methods

The selected projects will then be invited to submit a full study proposal. Usually, applicants will receive notification on whether their project was selected within 6 weeks. 

The decision as to whether Bayer invites for submission will be made at the sole discretion of Bayer.

3. Receipt of full study proposal & payment of grant to employer/institution

Those applicants that are invited shall prepare and hand in within approximately 4 weeks a detailed non-confidential study protocol, including detailed study planning with statistical considerations, project rationale, detailed costs and timelines, confirmation that all prerequisites for performing the intended research are available at the applicant’s institute (approximately 10-15 pages), as well as publications indicating the applicant’s expertise in the proposed indication and supporting the mechanistic approach to use the intended drug in the proposed indication.

Upon receipt of this full proposal, the grant of 5000€ will be paid out to the applicants institution*.

*if in accordance with your local laws and compliance regulations

Please note that any information that you submit is non-confidential.

4. Assessment & IIR agreement

The submitted detailed study protocols will again be reviewed and scored. The Bayer-internal Grants4Indications™ Review Committee will then, according to the overall rating, select those projects that Bayer is interested in funding. This funding includes the (fair market value) costs of the study plus the substance / drug in sufficient quantities and formulations.

The funding of such studies will be subject to a contract between applicant and Bayer, which will be negotiated upon notification to the applicant that Bayer intends to pursue the proposed research. The terms and conditions of such a contract will include a consideration to Bayer for the financial support of the study. In general, applicant will become owner of the results of the studies, yet with certain licenses and license options to Bayer, to be negotiated.

The decision as to whether Bayer enters into an agreement under which Bayer provides further support will be made at the sole discretion of Bayer.

Questions You Might Have

Who is eligible to apply?
Researchers from universities and other academic research institutes from all over the world are invited to apply.

Will the information provided be considered confidential?
No, the information provided will not be considered confidential.

Who will review the proposals?
The proposals will be reviewed by experienced scientists at Bayer from different functions.

Can I submit a proposal on behalf of a group?
Yes, you can submit a proposal on behalf of a group. However, please name your collaborators/coworkers; signatures of representatives of your institution/organization might be needed during the assessment period. Please also note, that we give one grant per one application to the main applicant’s institution, if accepted.

Do you have further questions? Get in touch!

*
Required fields, please complete.
Please note that the information you send is non-confidential.
You will receive a confirmation email after your inquiry.

Thank you for your inquiry! We will reply with a confirmation to the email address that you have provided.

OK

Submission is closed at the moment

The submission for Grants4Indications is closed now. We are happy to let you know when our submission is opening again. Simply sign up for our newsletter here.

If you already have a great idea, you can prepare the contents of your short proposal already. Take a look at our checklist as a general outline on what to include in your short proposal and what else has to be handed in to apply for a grant.

Your Submission Checklist
  • New indication for Bayer compound
  • Amount of compound that shall be used
  • Cost estimation, timing, services needed
  • Study design (clinical or non-clinical)
  • CV & relevant publications
Please be aware that all information you provide
is non-confidential.

Please sign me up for the newsletter.

We will keep you up to date with all things regarding Grants4Indications.

*Bayer will not send any additional emails to you or distribute your email address.

Thank you!
You have succesfully signed up for the Grants4Indications newsletter.

More Open Innovation By Bayer

Open Innovation Portal

Bring your ideas and projects together with people who can make it happen and share our passion for new paths in life sciences.

Visit site

Grants4Targets

Bayer provides grants for targets/biomarkers and offers expertise, tools and technologies to help develop your ideas.

Visit site

Grants4Apps

Bayer offers grants for the development of innovative app projects contributing to improve health outcomes or pharmaceutical processes.

Visit site

Contact us

Grants4Indications™ - Bayer Pharma AG
Müllerstr. 178. 13353 Berlin

grants4indications@bayer.com

Thanks for your message!

We will contact you shortly.

×